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molecules into well-defined complexes; and (3), nano-Nano-Tailoring:
scale redesigns, utilizing existent biogenic assembliesStitching Alterations of the proper dimension and altering their chemical com-
on Viral Coats position to attain a desired structure and/or function.
Viruses are intrinsically attractive scaffolds for nano-
scale constructions because they are predisposed for
self-assembly to form highly stable symmetrical struc-
tures with dimensions in the tens of nanometers. TheGrowing interest in utilizing protein assemblies for
nanomaterials applications has spawned efforts to detailed three-dimensional structures are often known
customize these scaffolds. Viral capsids have been from X-ray crystallography, and it is possible to intro-
modified with new chemical functionalities, typically duce specific positions of chemical reactivity on viral
at lysine or cysteine residues. Two innovative studies proteins through standard site-directed mutagenesis
describe approaches to introduce modifications at vi- protocols. Virions can even be produced cost effectively
rion tyrosine residues [1, 2]. on the gram scale. Self-assembly does not end at the
level of the individual capsid; in many cases, the viral
particles can be readily crystallized, even after modifica-The quest to create new nanometer-sized chemical ar-
tion, leading to organization of nanoblock arrays on thechitectures continues to accelerate, primarily along three
millimeter scale. A number of research groups are rap-broad trajectories: (1) top-down designs, using micro-
idly expanding the repertoire for nanochemistry on bio-lithographic and other techniques to embed increasingly
logical scaffolds [3]. Substantial effort has been devotedsmaller features into macroscopic materials; (2) bottom-
to utilizing biopolymers as templates for organized for-up designs, using the techniques of supramolecular chem-
istry to control the self-assembly of multiple constituent mation of inorganic materials [4, 5]. Recently, progress
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allowed for a small thiol-specific reagent to modify allTable 1.
60 copies of a specific cysteine residue on the interior
Protein Assemblies Used for Substituents Coupled to
surface of the capsid exclusively. Development of a mu-Nanometer-Scaled Scaffolds Protein-Based Scaffolds
tant CPMV with an additional solvent-exposed cysteine
cowpea mosaic virus fluorescent dyes residue allowed the attachment of fluorophores on the
(CPMV) biotin exterior surface [8].
M13 bacteriophage carbohydrates (e.g.,
A variety of different moieties have now been dis-tobacco mosaic virus (TMV) mannose)
played by conjugation to viral particles (Table 1). Thesecowpea chlorotic mottle antigenic groups (e.g.,
include antigenic groups (stilbene) [6], biotin [7, 8], goldvirus (CCMV) stilbene)
bacteriophage MS2 gold nanoparticles clusters [8], carbohydrates [9], and polyethylene glycol
filamentous bacteriophage semiconductor materials [10]. Viruses have been used to synthesize and assemble
(Ff and Fd) (e.g., GaAs, ZnS, and inorganic materials for the formation of nanowires,
hepatitis B virus (HBV) CdS)
nanotubes, and liquid crystals [4, 5]. Alternatively, engi-immunoglobulins magnetic materials (e.g.,
neered viruses displaying binding peptides or reactiveC4-symmetric tetrameric FePt, CoPt)
thiols can be immobilized upon patterned inorganic sub-aldolase (RhuA) peptide libraries
leucine zipper proteins polyethylene glycol strates [11].
chaperonin In the long term, the usefulness of virus-based scaf-
ferritin folds as building blocks for nanoscale assemblies may
depend on two criteria: (1) the stability of the overall
assembly, and (2) the access to orthogonal chemistries
has been made in the use of protein assemblies as that allow introduction of specific modifications at dis-
covalent reagents, including the conjugation of an in- tinct sites on the viral particles. Recent advancements
creasing variety of pendant groups, efforts to introduce from the Finn group and the Francis group show that it
new synthetic routes for addressing alternative chemical is also possible to selectively utilize tyrosine residues to
functionalities, and the development of new biological attach olefin and disulfide substrates onto these protein
scaffolds to embellish. assemblies (see Figure 1).
Discoveries in the Finn group have featured covalent Francis and coworkers describe an efficient strategy
modifications to the cowpea mosaic virus (CPMV), an based on a hetero Diels-Alder reaction for the attach-
icosahedral assembly comprised of 60 copies of a large ment of olefin substrates to modified tyrosine residues
and small protein subunit. Standard maleimide or bro- on bacteriophage MS2 [2]. A three-step synthetic se-
moacetamide reagents have been used to introduce quence was used to convert tyrosine residues on the
fluorescent dyes at cysteine residues, while N-hydroxy- phage particle first to o-amino tyrosine and then to
succinimide esters and isothiocyanate reagents have o-imino-quinone, which served as the diene platform for
been conjugated at lysine residues [6–8]. The absence the subsequent Diels-Alder reaction.
of cysteine residues on the outside surface combined In a related approach, the Finn group utilized mild
oxidation chemistry to prepare tyrosyl radicals that se-with the somewhat porous nature of the virion structure
Figure 1. Strategies for Specific Chemical Modification of Viral Particles to Generate Virus-Based Scaffolds for Nanomaterials
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The heparin polysaccharide is among the most acidicHeparin-Induced Cancer
of all natural products with a single molecule carryingCell Death from 75 to 100 negative charges [1]. As a result, heparin
interacts with a large number of proteins and other basic
molecules through ionic and hydrogen bonding interac-
tions [2]. A widely used therapeutic anticoagulant, hepa-Heparin uptake into cancer cells can be promoted
rin is biosynthesized and stored intracellularly exclu-by conjugation to poly (-amino ester)s. Internalized
sively in mast cells. Mast-cell-rich animal tissues, suchheparin is cytotoxic, causing cancer cell death by in-
as porcine intestine and bovine lung, are used as com-terfering with transcription factor activity and inducing
mercial sources of heparin. Many of the biological activi-apoptosis, but only certain poly(-amino ester)s pro-
mote this activity. ties ascribed to heparin (i.e., anticoagulation, regulation
